Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 5
1951 2
1952 2
1953 12
1954 5
1955 8
1956 19
1957 7
1958 11
1959 4
1960 4
1961 8
1962 14
1963 5
1964 4
1965 1
1966 3
1967 3
1968 3
1969 8
1970 3
1971 3
1972 2
1973 5
1974 4
1975 3
1976 4
1977 11
1978 4
1979 2
1980 8
1981 8
1982 3
1983 1
1984 5
1985 5
1986 4
1987 3
1988 8
1989 8
1990 1
1991 10
1992 15
1993 18
1994 7
1995 11
1996 24
1997 11
1998 8
1999 10
2000 11
2001 11
2002 12
2003 20
2004 20
2005 22
2006 29
2007 19
2008 21
2009 26
2010 29
2011 19
2012 18
2013 15
2014 22
2015 22
2016 22
2017 24
2018 16
2019 18
2020 14
2021 17
2022 11
2023 22
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

757 results

Results by year

Filters applied: . Clear all
Page 1
Transcription-coupled nucleosome assembly.
Robert F, Jeronimo C. Robert F, et al. Trends Biochem Sci. 2023 Nov;48(11):978-992. doi: 10.1016/j.tibs.2023.08.003. Epub 2023 Aug 30. Trends Biochem Sci. 2023. PMID: 37657993 Review.
[Hepatopulmonary syndrome].
Sayadi A, Duhaut L, Robert F, Savale L, Coilly A. Sayadi A, et al. Among authors: robert f. Rev Med Interne. 2024 Mar;45(3):156-165. doi: 10.1016/j.revmed.2023.03.008. Epub 2023 Mar 31. Rev Med Interne. 2024. PMID: 37005097 Review. French.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: robert f. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Future treatments for hereditary hemorrhagic telangiectasia.
Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige JJ. Robert F, et al. Orphanet J Rare Dis. 2020 Jan 7;15(1):4. doi: 10.1186/s13023-019-1281-4. Orphanet J Rare Dis. 2020. PMID: 31910860 Free PMC article. Review.
Leukaemia cutis.
Kumar N, Yadav S, Reddy V, Robert F. Kumar N, et al. Among authors: robert f. Lancet. 2012 Sep 29;380(9848):1179. doi: 10.1016/S0140-6736(12)60352-3. Epub 2012 Jun 15. Lancet. 2012. PMID: 22704804 No abstract available.
Contact lens embedded holographic pointer.
Robert FM, Abiven B, Sinou M, Heggarty K, Adam L, Nourrit V, de Bougrenet de la Tocnaye JL. Robert FM, et al. Sci Rep. 2023 Apr 27;13(1):6919. doi: 10.1038/s41598-023-33420-8. Sci Rep. 2023. PMID: 37106122 Free PMC article.
757 results